The blood test identifies the body's immune response to substances produced by tumour cells
Periods of exercise in the studies ranged from 30 to 80 minutes and were performed on one to five days a week for up to 12 weeks
These findings, published in the journal BMJ, identify a need for future research
Targeting this switch with a different drug could help reverse this resistance
Niramai has developed an artificial intelligence-based solution for detecting early-stage breast cancer.
Breast cancer's shockingly high fatality rate in India is due in large part to the fact that it is mostly detected at later stages
Breast cancer survivors also had up to twice the risk of depression
Digital mammogram with tomosynthesis is a superb tool to detect even very small cancer
Zydus Cadila has more than 220 approvals and so far
The study included participants who had a normal BMI (between 18.5 to 25.0) and no history of breast cancer
Biocon said biosimilar trastuzumab will be manufactured by it and supplied to Libbs for commercialisation in Brazil
A recent study showed that these women seek medical care extremely late
To detect abnormalities in breasts, it is essential for adult women of all ages to perform a self examination five days after menstruation
The start-up has a central laboratory in Bengaluru to test all samples
Roche has filed for a patent for its new drug formulation meant for subcutaneous administration
Medical community for many years has focused on identifying cancer early so that it can be cured
Some therapies despite being convenient and less expensive, is associated with high cancer risks
Niramai offers thermo analytics-based cancer screening solution that helps detect breast cancer early
Bengaluru-based Niramai uses machine learning and cloud-based screening as well, Tech in Asia
Roche hopes the important trial outcome will help shield its oncology franchise from cheaper copies